Page 1 | Search Results | Blood | American Society of Hematology

Skip Nav Destination

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Clinical features and outcomes of myelofibrosis patients with MPL mutations

Yu-Han Chen, Shruti Gajjar, Victor You, Rami Komrokji, Valentina Nardi, Harrison Tsai, Andrew Kuykendall, Gabriela Hobbs

Blood (2025) 146 (Supplement 1): 5601.

https://doi.org/10.1182/blood-2025-5601

Published: 2025

Journal Articles

Clinical features and outcomes of myeloproliferative neoplasm patients with MPL mutations and concurrent JAK2/calr mutations

Yu-Han Chen, Shruti Gajjar, Victor You, Rami Komrokji, Valentina Nardi, Harrison Tsai, Zhuoer Xie, Andrew Kuykendall, Gabriela Hobbs

Blood (2025) 146 (Supplement 1): 7354.

https://doi.org/10.1182/blood-2025-7354

Published: 2025

Journal Articles

Not so exclusive: Co-mutations in JAK2, MPL and CALR define distinct hematologic and clonal signatures

Ekrem Turk, Fernando Bustamante, Fatima Tuz Zahra, Yu-Han Chen, Rory Shallis, Onyee Chan, Samuel Reynolds, Alison Walker, Ling Zhang, Seongseok Yun, Jeffrey Lancet, David Sallman, Rami Komrokji, Jinming Song, Eric Padron, Gabriela Hobbs, Andrew Kuykendall, Zhuoer Xie

Blood (2025) 146 (Supplement 1): 3815.

https://doi.org/10.1182/blood-2025-3815

Published: 2025

Journal Articles

Effect of SGLT2 Inhibitors on Erythrocytosis and Arterial Thrombosis Risk in Patients with Type 2 Diabetes Mellitus: A Real-World Multi-Center Cohort Study across the United States

Yu-Han Chen, Tina Yi Jin Hsieh, Andrea Yue-En Sun, Natasha Rastogi, James Cheng-Chung Wei, Cho-Hao Lee

Blood (2024) 144 (Supplement 1): 5214.

https://doi.org/10.1182/blood-2024-207610

Published: 2024

Journal Articles

Impact of Early Antibiotic De-Escalation on Mortality in Febrile Neutropenia in Patients with Hematologic Malignancy Receiving Treatment: A Meta-Analysis

Yu-Han Chen, Andrea Yue-En Sun, Karishma Narain, Natasha Rastogi, Cho-Hao Lee

Blood (2024) 144 (Supplement 1): 3553.

https://doi.org/10.1182/blood-2024-198520

Published: 2024

Update search

NARROW

Publications

Format

Article Type

Date

Availability

Clinical features and outcomes of myelofibrosis patients with MPL mutations

Clinical features and outcomes of myeloproliferative neoplasm patients with MPL mutations and concurrent JAK2/calr mutations

Not so exclusive: Co-mutations in JAK2, MPL and CALR define distinct hematologic and clonal signatures

Effect of SGLT2 Inhibitors on Erythrocytosis and Arterial Thrombosis Risk in Patients with Type 2 Diabetes Mellitus: A Real-World Multi-Center Cohort Study across the United States

Impact of Early Antibiotic De-Escalation on Mortality in Febrile Neutropenia in Patients with Hematologic Malignancy Receiving Treatment: A Meta-Analysis

Email alerts

ASH Publications

American Society of Hematology

Update search

Clinical features and outcomes of myelofibrosis patients with MPL mutations

Clinical features and outcomes of myeloproliferative neoplasm patients with MPL mutations and concurrent JAK2/calr mutations

Not so exclusive: Co-mutations in JAK2, MPL and CALR define distinct hematologic and clonal signatures

Effect of SGLT2 Inhibitors on Erythrocytosis and Arterial Thrombosis Risk in Patients with Type 2 Diabetes Mellitus: A Real-World Multi-Center Cohort Study across the United States

Impact of Early Antibiotic De-Escalation on Mortality in Febrile Neutropenia in Patients with Hematologic Malignancy Receiving Treatment: A Meta-Analysis

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only